Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing sales7@sinochem-nanjing.com 3389378665@qq.com
Follow us:

(3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester

    • Product Name (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester
    • Alias tert-Butyl (3-iodopyridin-4-yl)carbamate
    • Einecs EINECS 695-990-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry sales7@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    866764

    Product Name (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester
    Cas Number 1048975-93-6
    Molecular Formula C10H13IN2O2
    Molecular Weight 320.13
    Appearance Off-white to pale yellow solid
    Melting Point 97-101°C
    Purity Typically >98%
    Smiles CC(C)(C)OC(=O)Nc1ccncc1I
    Inchikey NQWOVAAJVZXQBB-UHFFFAOYSA-N
    Solubility Soluble in DMSO, DMF, slightly soluble in methanol
    Storage Conditions Store at 2-8°C, protect from light and moisture

    As an accredited (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The chemical comes in a 5-gram amber glass bottle with a secure screw cap, labeled with product information, safety warnings, and CAS number.
    Shipping The chemical `(3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester` is shipped in tightly sealed, chemically resistant containers under ambient or cool conditions. Packaging complies with international transport regulations for hazardous chemicals. Proper labeling, documentation, and cushioning are included to prevent breakage or contamination during transit, ensuring safe and secure delivery.
    Storage Store **(3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester** in a tightly sealed container under a dry, inert atmosphere such as nitrogen or argon. Keep it at 2–8°C (refrigerator temperature), away from light, moisture, and incompatible substances like acids or oxidizers. Ensure storage in a well-ventilated, designated chemical area, and use appropriate protective equipment when handling.
    Application of (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester

    Applications of (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester in Industrial Manufacturing

    As an integrated manufacturer of (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester, we supply this intermediate to partners across the pharmaceutical and advanced agrochemical industries. Below, we detail key application segments where our material supports specialized production, focusing on authentic downstream use, compliance adherence, and processing needs in each scenario.

    1. Small Molecule Pharmaceutical Synthesis

    This protected pyridine derivative serves as a building block in the synthesis of kinase inhibitors and central nervous system (CNS) actives. Process teams use it at the intermediate stage to drive selectivity and manage side reactions, supporting high-purity active pharmaceutical ingredient (API) manufacturing in both pilot and full-scale GMP environments. The raw material is introduced during multi-step organic transformations, and its use underpins several proprietary and generic compound registrations globally.

    Industry compliance standards

    • ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • US FDA 21 CFR Part 211
    • EU GMP Volume 4, Annex 1 & 2
    • Applicable EMA and JP Pharmacopeia for intermediate validation

    Typical usage ratio

    • 5–20% molar equivalent relative to target substrate; final ratio optimized based on target molecule's step-yield and side-product suppression

    Downstream process integration

    • Charged during Stage 2–4 of stepwise API synthesis under anhydrous, controlled-environment batch reactors
    • Deprotection and subsequent functionalization occur prior to later purification/crystallization steps

    Final product types

    • Oral kinase inhibitor tablets and capsules
    • Parenteral CNS therapeutic APIs
    • Portfolio drug candidates in advanced clinical phases

    2. Advanced Agrochemical Active Ingredient Manufacturing

    Within the crop protection sector, this compound is utilized in the fine chemical synthesis of pyridine-based herbicides and insecticides. Formulators leverage its steric protection to control regioselectivity during the coupling and halogenation stages, enabling production teams to achieve clean conversions that support EU and EPA regulatory dossiers.

    Industry compliance standards

    • FAO/WHO Specifications for Plant Protection Products
    • ISO 9001:2015 for agrochemical intermediates
    • REACH (EC 1907/2006) registration for imported intermediates
    • EPA 40 CFR Part 158 (for USA-bound actives)

    Typical usage ratio

    • 3–10% by mol in key coupling reactions; adjusted per synthetic pathway and desired active content

    Downstream process integration

    • Added prior to nitration or halogen exchange, in closed glass-lined or stainless steel reactors
    • Deprotection sequence follows primary functionalization, with solvent exchange and extraction preceding formulation

    Final product types

    • Pyridine-based herbicide technical concentrates
    • Insecticide active intermediates for formulation into EC and SC products
    • Regulatory sample batches for registration dossiers

    3. Pharmaceutical Process Research and Development (R&D) Intermediates

    Chemical development groups in generic and branded pharmaceutical environments apply this material for process optimization and scale-up studies. Chemists utilize it to investigate alternative pyridine substitutions and to optimize deprotection protocols under simulation of industrial conditions, allowing for data generation ahead of full validation and registration.

    Industry compliance standards

    • Good Laboratory Practice (GLP, OECD Principles)
    • USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products (applied during API process development)
    • ICH Q2(R1): Analytical Validation

    Typical usage ratio

    • 1–10 mmol per R&D batch; selection guided by process simulation scale and targeted impurity profile assessment

    Downstream process integration

    • Weighing and charging as a process variable for reaction design-of-experiment (DoE) studies
    • In-process monitoring of conversion and impurity mapping

    Final product types

    • Process validation samples for regulatory CMC submissions
    • Reference standards for analytical method development
    • Pilot-scale API intermediates for ongoing project scale-up work

    4. Custom Synthesis of Specialty Heterocyclic Intermediates

    CRO and CDMO organizations employ this carbamate ester in the multistep synthesis of custom heterocyclic scaffolds used for molecular discovery, including candidates for anti-infective and anti-inflammatory screening. Its protection group improves handleability during air- and moisture-sensitive transformations, facilitating efficient delivery of complex building blocks to discovery chemistry teams and early preclinical programs.

    Industry compliance standards

    • ISO 13485: Quality Management for Life Science R&D Materials (when intermediates feed clinical pipeline)
    • Internal SOPs aligned with client auditing requirements (e.g., Eli Lilly, Novartis, Pfizer)
    • OECD GLP for regulated preclinical contract work

    Typical usage ratio

    • 2–8 equivalents depending on the complexity of the heterocycle and the number of desired substitutions; reviewed per synthetic route with client input

    Downstream process integration

    • Intake at early-stage multi-gram synthesis
    • Isolation of protected/intermediate species by chromatographic separation post-coupling; full deprotection performed prior to shipment or handed off for client conversion

    Final product types

    • Drug discovery heterocyclic libraries
    • Advanced intermediates for SAR (structure-activity relationship) programs
    • Material transfer batches for collaborative research projects
    Free Quote

    Competitive (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: sales7@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester: Setting a New Standard in Pyridine-Based Intermediates

    A Chemical Manufacturer’s Perspective on Building Chemistry, Molecule by Molecule

    (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester has become a staple in our production lines and process development workbenches. Every gram of this compound that leaves our facility represents more than just adherence to catalog requirements. It reflects years of learning from both successes and laboratory setbacks, driven by the constantly evolving needs of the pharmaceutical and specialty synthesis sectors. Being direct manufacturers, we face the actual challenge of translating bench chemistry—designed in ideal conditions—into something that can be replicated reliably at a larger scale. With this molecule, project teams need more than theoretical purity; they rely on consistency, and we understand the difference firsthand.

    Our Path to Reliability and Authentic Quality

    Manufacturing (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester requires more than just good intentions. The starting materials—each specified for known impurity profiles—allow us to maintain a synthesis route that yields this carbamate with a high standard of chemical cleanliness. Over the years, small process optimizations based on real-time data improved yields and reproducibility. Our operators look for more than a passing HPLC: they examine the full impurity fingerprint, making sure contaminants like unreacted pyridine, over-iodination side products, and tert-butyl cleavage fragments don't find their way into the final container.

    Process engineers in our facilities constantly confront the daily realities of moisture ingress, batch inconsistencies, and purification bottlenecks. Experience has shown us that even slight temperature drifts or batch times often led to subtle color changes or crystalline habit shifts—each indicating a difference that can ripple down a customer’s synthetic pathway. For medicinal chemistry clients, these nuances matter, especially where a tiny percentage of byproduct becomes magnified in scale-up or bioassay.

    The Specification Story: Linking Process and User Needs

    We manufacture (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester under specifications developed through ongoing conversation with research chemists and production managers who use our product onsite. Our output typically achieves a purity of over 98% by HPLC (assay by area normalization), with residual volatile solvents kept well below 0.5%. Controlled moisture—assured by Karl Fischer titration—keeps hydrolysis at bay, particularly during warmer months when humidity challenges every operator’s patience. Each lot comes with a detailed impurity profile from both NMR and mass spectrometry, but our QC teams like to interpret these results in the context of real synthesis, not just digital numbers.

    Solid-state characterization matters for this compound because its functional groups make it sensitive to both light and heat, and we often encounter minor color changes that can hint at underlying instability. These observations aren’t just quirks: they tell us when a modification in our process or packaging is needed, whether it’s changing from clear to amber glass or adding additional desiccants.

    Why This Pyridine Derivative?

    We see consistent interest in (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester from projects that require a protected, iodo-substituted pyridine scaffold. Its reactivity profile has particular value in palladium-catalyzed cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig reactions. The iodine acts as an excellent leaving group, providing high regioselectivity for introducing complex fragments onto the pyridine core.

    The tert-butyl carbamate—sometimes called “Boc”—protects the amine during harsh reaction steps, giving chemists more freedom in functional group manipulation while minimizing unwanted side reactions. This protection remains stable under a range of typical workup conditions, which reduces the risk of unwanted deprotection that might complicate downstream steps.

    Our feedback loop with users—by way of performance complaints or new method requests—forces us to stay opinionated about stability and packaging. More than once, we have extended our shelf-life claims only after tracking real-time stability over several seasons, sometimes changing storage recommendations in response to how actual labs use our chemical. These changes—beyond what standard safety data might instruct—make a measurable difference for scale-ups and pilot programs.

    Performance Versus Standard Alternatives

    As a manufacturer, we have a close perspective on the practical differences between (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester and related pyridine intermediates. Compared with its bromo-analogues, the iodo-derivative generally provides higher coupling yields and cleaner conversions in many cross-coupling protocols. While bromides offer some economic attraction due to price per kilo, they often come with higher reactivity risks in certain processes, requiring stricter vigilance. Iodide leaving groups cut down on side-product formation, leading to fewer isolated impurities after workup.

    There are unprotected 3-iodo-4-aminopyridines on the market, but direct use often introduces risk of multiple side-reactions—particularly N-alkylation, oxidation, or hydrolysis—because the free amine tends to react with a variety of unanticipated reagents or environmental traces. By providing the Boc-protected form, we help avoid extraneous purification steps, loss of overall yield, and additional waste.

    Our material’s reliable performance in scale-up and repetitive runs traces back to careful process controls added during tricky stages: especially the iodination and carbamate formation steps. Our operators, supported by well-tuned analytical equipment, are experienced enough to spot batch-to-batch variabilities early, flagging any trend before it jeopardizes a customer’s project timeline. We don’t treat these interventions as paperwork, but as the foundation of meaningful partnership with our industrial users.

    Understanding the End-Use: Bringing Manufacturer’s Insights into Your Lab

    In the real world of laboratory synthesis, the needs for (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester go beyond simple catalog descriptions. Clients use it as a key building block for heterocyclic drug candidates, pesticide actives, and even for specialty electronic materials. Often, our customer discussions turn from basic specifications to methodological advice—heat limits, storage requirements, and even recommended dissolution solvents. This engagement comes from decades spent manufacturing, not just reselling.

    A critical consideration in its application is solubility—users often note that solubilizing the product can be slow in non-polar solvents. Dense, crystalline appearance in batches can also impact how quickly it can be dissolved for reaction, leading our technical team to recommend gentle warming and the use of polar aprotic solvents. Batch-to-batch consistency is a big point for users running automated synthesis workflows, as even minor physical inconsistencies can translate into pipetting or weighting errors.

    We hear stories from researchers about bottlenecks they face with lower-purity material from “repack” sources—problems they could avoid by sourcing directly from producers willing to show their process and analytical data. As originators, we see ourselves becoming part of our clients’ quality management system, rather than just a remote supplier.

    Adaptation and Learning: Living with Process Risks

    Every run of (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester forces us to reassess risk mitigation strategies. With sensitive halogenated pyridine intermediates like these, trace contamination from cleaning agents, cross-batch volatility, or laboratory atmosphere can have cumulative effects over time. Our facilities are fitted with dedicated lines for key reagents and intermediate storage, limiting the problems of accidental mixing or unplanned quenching. A robust process isn’t just about avoiding the big mistakes—many lessons come from tackling small, chronic issues like raw material variability or analytical drift.

    Cycle times and cleaning protocols have evolved, based on close study of repeat reactions and operator input. During each campaign, line workers document subtle changes—crystal shape, ease of filtration, or faint odor differences. Each new insight feeds back into both control documentation and training. Fluctuations in iodine sourcing or changes in upstream reagents call for nimble purchasing and process adjustments long before a batch fails to meet target purity.

    Supporting Greener Chemistry and Responsible Production

    As manufacturers, our obligation covers not only end-product consistency but also the way our activities impact the environment and local communities. The production of (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester involves careful management of iodine, solvents, and amine-based intermediates, all of which bring real-world EHS (environment, health, and safety) challenges. The drive to work with safer solvents, capture fugitive emissions, and recycle iodine byproducts arose from necessity—regulatory attention and site audits push us to invest in better abatement equipment and updated training.

    Our environmental efforts include solvent recovery, load balancing to avoid unnecessary night-shift operation, and maximizing batch sizes to both minimize waste and lower energy per kilo produced. We take pride in process innovations that have reduced our average iodine consumption by several percent over the past five years—not because of outside pressure, but because wasted input is wasted money and risk. Our chemists’ focus includes byproduct fate tracking, making sure materials at each stage are tracked until their safe disposal or recovery.

    Competitive Value: Beyond the Purity Numbers

    Everyone boasts high-purity pyridine derivatives. Having controlled every step from raw materials to finished packing, we understand what these numbers mean—and how often they become unreliable if a process is optimized only for initial market approval rather than continuous, year-round production. Customers ask us about scaling performance, upstream traceability, and even operator training routines. Transparency around these issues helps clients avoid delayed launches and regulatory headaches.

    We believe value shows best in practical outcomes—minimal process disruption, consistent dosing, less caking or clumping in drums, and real-time support from people who authored the process in the first place. Our technical teams maintain close communication with purchasers, researchers, and production engineers far beyond the point of sale, because successful projects grow from long-term, reliable cooperation rather than transactional interactions.

    Research Partnerships and Customization: Growing Together

    Years of feedback from our partners have led to several process innovations for (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester. Some clients requested custom particle sizes or forms, tailored to their dispensing equipment. Others need tighter impurity controls due to new regulatory demands or synthesis plans. The flexibility to adapt a process for custom requirements draws on deep in-house experience and accumulated process data—not simply rebalancing off-the-shelf reagents.

    Collaborative development projects sometimes go further, such as designing a dedicated packaging solution that limits exposure to both light and moisture during transit. We have shared real-time monitoring data and proprietary stability studies with select partners, providing actual evidence for claiming shelf lives or recommending new ways of storing intermediates. With every custom request, our staff and process teams gain fresh perspective—whether adjusting a drying step, redesigning a filtration system, or recommending alternative analytical workflows.

    Final Thoughts: Building Trust Through Real Manufacturer Experience

    We see (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester as more than a static product entry; it is a living interface between complex manufacturing, advanced synthetic needs, and evolving industry standards. Our process choices and ongoing dialogue with end-users anchor the product’s reliability in practice, not just on paper. Every batch that leaves our factory embodies years of cumulative learning, technical care, and a willingness to adapt to the landscape of specialty chemicals.

    Anyone who seeks predictability, transparency, and real problem-solving capacity in their supply chain recognizes that working directly with manufacturers brings inherent advantages. Each kilogram of our (3-Iodo-Pyridin-4-Yl)-Carbamic Acid Tert-Butyl Ester represents an ongoing promise—to keep learning from user realities, to improve process and product, and to help research and manufacturing partners deliver on their own high standards.